Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 2 Uterine Cervical Neoplasms 1 Sarcoma 1 Pancreatic Neoplasms 1 Head and Neck Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1 Carcinoma, Bronchogenic 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

Ibandronic Acid 8 Gemcitabine 8 Doxorubicin 6 Cyclophosphamide 6 Zoledronic Acid 5 Radiation 4 Nivolumab 4 Irinotecan 4 pembrolizumab 3 Vincristine 3 Temozolomide 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Docetaxel 3 Denosumab 3 Cisplatin 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 regorafenib 2 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiosurgery 2 Quality of Life 2 Proton Therapy 2 Observation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Neoplasms × Exercise Therapy × Sarcoma × Clear all

NCT04963517 2024-12-06

proGAIT

Universität Duisburg-Essen

Phase 2/3 Completed

Bone Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡